TrialReader

Expanded Access to NanoPac

NCT03756311 — No longer available, NanOlogy, LLC
ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT03756311
StatusNo longer available
Study typeExpanded access
SponsorNanOlogy, LLC (Industry)
ConditionsLocally Advanced Pancreatic Carcinoma, Prostate Cancer, Lung Cancer
InterventionsNanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension (Drug)
Datesfirst posted 2018-11-28, last updated 2026-01-23

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Locally Advanced Pancreatic Carcinoma All trials for Prostate Cancer All trials of NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension

-Summary

NanOlogy may consider offering expanded access to NanoPac for patients who do not meet the enrollment criteria of clinical trials in progress.

Expand all sections  ·  Collapse all

+Arms and interventions

  • NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension (Drug), also known as Paclitaxel

+Eligibility

Sex: All

Inclusion Criteria:

\-

Exclusion Criteria:

\-

My Notes